S. 1387 · 119th Congress (2025–2027)
National Biotechnology Initiative Act of 2025
This bill establishes an interagency biotechnology initiative to coordinate and advance federal biotechnology activities, including research, product regulation, and national security efforts. The bill implements several recommendations issued by the National Security Commission on Emerging Biotechnology in its April 2025 final report.
Under the bill, agencies participating in the initiative must conduct or support biotechnology-related activities in coordination with the initiative, such as (1) supporting the development and commercialization of biotechnology products, (2) coordinating with industry on threat information sharing and risk mitigation, and (3) supporting the development of a domestic biotechnology workforce.
Further, the bill provides for an executive office and interagency committee to coordinate and support initiative activities.
Among other functions, the office must
- assess and address national security, economic security, and biosafety issues associated with emerging biotechnology;
- coordinate support for biotechnology research and development, including by supporting a national network of biotechnology testbeds;
- negotiate interagency agreements to establish clear regulatory pathways for biotechnology products; and
- develop an outreach strategy to improve international market access for U.S. biotechnology products.
The office and committee must jointly publish a website with information about federal biotechnology activities and must periodically publish and submit to Congress a comprehensive national strategy for biotechnology.
The Government Accountability Office must periodically review and report to Congress on the activities of the office and committee.
The office must wind down and transition most of its functions to the committee after 20 years.
Show official title
A bill to authorize the National Biotechnology Initiative, and for other purposes.
Referred to committee
Latest actionReferred to committee
This bill’s path
This is S. 1387’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed Senate
Passed House
Sent to President
Signed into law
- Sponsor
- Sen. Todd Young (R-IN)
- Cosponsors
1 cosponsor
1 original · 0 later
- Sen. Alex Padilla (D-CA)· Original · Apr 9, 2025
- Policy area
- Science, Technology, Communications
- Subjects
- Administrative law and regulatory procedures
- Advanced technology and technological innovations
- Advisory bodies
- Biological and life sciences
- Congressional oversight
- Data collection, sharing, protection
- Employment and training programs
- Executive Office of the President
6 more
- Executive agency funding and structure
- Government information and archives
- Internet, web applications, social media
- Research administration and funding
- Research and development
- Technology transfer and commercialization
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in Senate
Document: Introduced in Senate
Sources
- Congress.gov action
- Library of Congress
- Latest
Referred to committee
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sources
- Congress.gov action
- Senate
Committees
- SenateHealth, Education, Labor, and PensionsReferred Apr 9, 2025 · Hearings by (full committee) Mar 19, 2026
Mar 19, 2026 · Meeting
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in Senate |
Titles (2)
National Biotechnology Initiative Act of 2025
Display title, Short title · Introduced in Senate
A bill to authorize the National Biotechnology Initiative, and for other purposes.
Official title · Introduced in Senate